Lilly’s Taltz scrapes win against Humira in psoriatic arthritisEli Lilly’s Taltz has beaten AbbVie’s blockbuster Humira in a psoriatic arthritis study involving patients who hadn’t been Share XLilly’s Taltz scrapes win against Humira in psoriatic arthritishttps://pharmaphorum.com/news/lillys-taltz-scrapes-win-against-humira-in-psoriatic-arthritis/
GSK makes CRISPR play, funding Doudna lab in CaliforniaGlaxoSmithKline has forged an alliance with two leading CRISPR researchers that will see the creation of a new Share XGSK makes CRISPR play, funding Doudna lab in Californiahttps://pharmaphorum.com/news/gsk-makes-crispr-play-funding-doudna-lab-in-california/
Sobi cuts staff and buys Novimmune drug in refocusSobi has narrowed its focus to haematology and immunology, shedding staff and R&D projects in other areas whilst Share XSobi cuts staff and buys Novimmune drug in refocushttps://pharmaphorum.com/news/sobi-cuts-staff-novimmune-drug-refocus/
Continuous bioprocessing – the key to industrialising gene therapy production?A new partnership, with funding from Innovate UK, aims to investigate the possibility of using continuous manufacturing processes Share XContinuous bioprocessing – the key to industrialising gene therapy production?https://pharmaphorum.com/r-d/views-analysis-r-d/continuous-bioprocessing-the-key-to-industrialising-gene-therapy-production/
Propeller Health: respiring for successDavid Van Sickle is on a mission to transform treatment for respiratory diseases with the company he co-founded, Share XPropeller Health: respiring for successhttps://pharmaphorum.com/r-d/views-analysis-r-d/propeller-health-respiring-for-success/
Nine for 2019: Opportunities for pharmaIn the last Nine for 2019 article, we reflected on the major challenges that are shaping the pharmaceutical Share XNine for 2019: Opportunities for pharmahttps://pharmaphorum.com/views-and-analysis/nine-for-2019-opportunities-for-pharma/
Navigating new frontiers: Ways to find space in the future RA marketOverview Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15 Share XNavigating new frontiers: Ways to find space in the future RA markethttps://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/
Understanding blockchain – a practical guide for life sciences companiesWithin the life science industry, uptake of blockchain is in the early stages, but with investment levels in Share XUnderstanding blockchain – a practical guide for life sciences companieshttps://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/
Marketing science – brand innovation for pharmaCombining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as Share XMarketing science – brand innovation for pharmahttps://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/
Insights into HPAPI Containment and Banding StrategiesHPAPI USA Updates Share XInsights into HPAPI Containment and Banding Strategieshttps://pharmaphorum.com/partner-content/insights-into-hpapi-containment-and-banding-strategies/
5th Annual Lyophilization Conference USALyophilization Updates Share X5th Annual Lyophilization Conference USAhttps://pharmaphorum.com/events/5th-annual-lyophilization-conference-usa/
Highly Potent Active Pharmaceutical Ingredients USA (HPAPI) ConferenceHPAPI Strategies Share XHighly Potent Active Pharmaceutical Ingredients USA (HPAPI) Conferencehttps://pharmaphorum.com/events/highly-potent-active-pharmaceutical-ingredients-usa-hpapi-conference/
